Drugs / TNFerade biologic
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01048151 | — | castration-resistant prostate carcinoma | GenVec | Unknown | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00496236 | — | head and neck cancer | GenVec | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TNFerade biologic | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00496236 ↗ |
| Route | Other | “INTRATUMORAL INJECTIONS” NCT01048151 ↗ |